Physician profile
Barton Wachs
NPI 1366461832
$10,765.29
in general payments reported to CMS, 2019-2025
54 companies · $1,465 in 2025
The $1,465 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,290 · 2020: $769 · 2021: $1,283 · 2022: $2,952 · 2023: $1,047 · 2024: $1,959 · 2025: $1,465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,061 · Travel and Lodging: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,061.41 |
| Travel and Lodging | $410.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $1,975.18 | 2022-2025 | Nanoknife |
| Astellas Pharma US INC | $1,275.21 | 2019-2025 | Xtandi, Myrbetriq |
| Boston Scientific Corporation | $935.09 | 2019-2024 | Lumenis Pulse 120h, Ams 700 |
| Agiliti Surgical, INC. | $802.90 | 2023-2025 | Sonablate Hifu, Koelis Trinity Mri/US Fusion, Sonablate |
| Pfizer INC. | $790.37 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $488.62 | 2023-2025 | Orgovyx, Gemtesa |
| Myriad Genetic Laboratories, INC. | $410.84 | 2022-2023 | Prolaris, Myrisk |
| Endo Pharmaceuticals INC. | $389.54 | 2019-2024 | Xiaflex, Aveed |
| Progenics Pharmaceuticals, INC. | $351.86 | 2022-2024 | Pylarify |
| Dendreon Pharmaceuticals LLC | $315.27 | 2019-2025 | Provenge |
| Teleflex LLC | $313.62 | 2021-2025 | Barrigel, Urolift |
| Coloplast Corp | $284.65 | 2019-2025 | |
| Allergan, INC. | $222.94 | 2019-2022 | |
| Procept Biorobotics Corporation | $214.56 | 2022-2023 | Aquabeam Robotic System |
| Myovant Sciences INC. | $144.07 | 2021-2022 |
Show all 52 companies
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barton Wachs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.